chitosan and plga microspheres as drug delivery ... - UniCA Eprints

9. References219. Berthold A., Cremer K., Kreuter J. Preparation and characterization of chitosan microspheresas drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J.Control Rel. vol. 39, p. 17-25, 1996a.220. Berthold A., Cremer K., Kreuter J. Influence of crosslinking on the acid stability andphysicochemical properties of chitosan microspheres. STP Pharm. Sci. vol. 6, p. 358-364, 1996b.221. Hejazi R., Amiji M. Stomach-specific anti-H. pylori therapy. I: preparation andcharacterization of tetracylineloaded chitosan microspheres. Int. J. Pharm. Vol. 235, p. 87-94,2002.222. Jameela S.R., Kumary T.V., Lal A.V., Jayakrishnan A. Progesterone-loaded chitosanmicrospheres: a long acting biodegradable controlled delivery system. J. Control Rel. vol. 52, p.17-24, 1998.223. Kumar V., Lewis S.A., Mutalik S., Shenoy D.B., Udupa N. Biodegradable microspheres ofcurcumin for treatment of inflammation. Indian J. Physiol. Pharmacol. vol. 46, p. 209-217, 2002.224. Dini E., Alexandridou S., Kiparissides C. Synthesis and characterization of cross-linkedchitosan microspheres for drug delivery applications. J. Microencapsul. Vol. 20, p. 375-385, 2003.225. Tsapis N., Bennett D., O’Driscoll K. et al. Direct lung delivery of para-aminosalicylic acid byaerosol particles. Tuberculosis (Edinburgh, Scotland). Vol. 83, p. 379-85, 2003.226. Athanasiou K.A., Niederauer G.G., Agrawal C.M. Sterilization, toxicity, biocompatibility andclinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials. Vol. 17, p. 93-102, 1996.227. Göpferich A. Mechanisms of polymer degradation and erosion. Biomaterials. Vol. 17, p. 103-114, 1996a.228. Göpferich A. Polymer degradation and erosion: mechanisms and application. Eur. J. Pharm.Biopharm. Vol. 42, p. 1-11, 1996b.229. Husmann M., Schenderlein S., Lück M., Lindner H., Kleinebudde P. Polymer erosion inPLGA microparticles produced by phase separation method. Int. J. Pharm. Vol. 242, p. 277-280,2002.230. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonistleuprorelin acetate. Adv. Drug. Del. Rev. vol. 28, p. 43-70, 1997.231. Hausberger A.G., DeLuca P.P. Characterization of biodegradable poly(D,L-lactidecoglycolide)polymers and microparticles. J. Pharm. Biomed. Anal. Vol. 13, p. 747-760, 1995.232. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactidecoglycolide)(PLGA) devices. Biomaterials. Vol. 21, p. 2475-2490, 2000d.233. Jamshidi K., Hyon S.H., Ikada Y. Thermal characterization of polylactides. Polymer. vol. 29,p. 2229-2234, 1988.234. Park T.G. Degradation of poly(D,L-lactic acid) microspheres: effect of molecular weight. J.Control. Release. Vol. 30, p. 161-173, 1994.235. Li S. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic andglycolic acids. J. Biomed. Mater. Res. Vol. 48, p. 342-353, 1999.236. Ogawa Y., Yamamoto M., Takada S., Okada H., Shimamoto T. Controlled-release ofleuprolide acetate from polylactic acid or copoly(lactic / glycolic) acid microcapsules: influence ofmolecular weight and copolymer ratio of polymer. Chem. Pharm. Bull. Vol. 36, p. 1502-1507,1988.237. Omelczuk M.O., McGinity J.W. The influence of polymer glass transition temperature andmolecular weight on drug release from tablets containing poly(DL-lactic acid). Pharm. Res. Vol.9, p. 26-32, 1992.238. Bodmeier R., Oh K.H., Chen H. The effect of the addition of low molecular weightpoly(DLlactide) on drug release from biodegradable poly(DL-lactide) drug release systems. Int. J.Pharm. Vol. 51, p. 1-8, 1989.239. Wada R., Tabata Y., Ikada Y. Preparation of poly(lactic acid) microspheres containing anticanceragents. Bull Inst Chem Res. Vol. 66, p. 241-250, 1988.240. Okada H., Yamamoto M., Heya T., Inoue Y., Kamei S., Ogawa Y., Toguchi H. Drug deliveryusing biodegradable microspheres. J Controlled Release. Vol. 28, p. 121-129, 1994.132